FY26 Annual Report SOLVING URGENT VIRAL DISEASE THREATS Island Pharmaceuticals Limited 3 Island Pharmaceuticals Limited ACN 641 183 842 Contents Corporate directory Chair letter to shareholders CEO letter to shareholders Directors’ report Auditor’s independence declaration...
Annual Report to shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- Preliminary Final Report
- Island boosts Galidesivir supply as Ebola surges
- Date of AGM & Closing Date for Director Nominations
- Cleansing Notice
- Application for quotation of securities - ILA
Later from Island Pharmaceuticals
- Appendix 4G and Corporate Governance Statement
- Pivotal Marburg data secured for Galidesivir FDA pathway
- Annual General Meeting - Rescheduled Date
- Galidesivir GMP manufacturing commences
- Notification regarding unquoted securities - ILA
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals